How big is the Biotechnology Market?

The Biotechnology Market size is expected to reach USD 1.30 trillion in 2024 and grow at a CAGR of 9.26% to reach USD 2.02 trillion by 2029. Read More

What is the current Biotechnology Market size?

In 2024, the Biotechnology Market size is expected to reach USD 1.30 trillion. Read More

Who are the key players in Biotechnology Market?

Johnson & Johnson, Roche Holdings AG, Novartis International, Amgen Inc. and Gilead Science Inc. are the major companies operating in the Biotechnology Market. Read More

Which is the fastest growing region in Biotechnology Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Biotechnology Market?

In 2024, the North America accounts for the largest market share in Biotechnology Market. Read More

What years does this Biotechnology Market cover, and what was the market size in 2023?

In 2023, the Biotechnology Market size was estimated at USD 1.18 trillion. The report covers the Biotechnology Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Biotechnology Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Biotechnology Market Share

Statistics for the 2023 & 2024 Biotechnology market share, created by Mordor Intelligence™ Industry Reports. Biotechnology share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Biotechnology Industry

The biotechnology market is consolidated and features key players like Johnson & Johnson, Roche Holdings AG, and Novartis International. Market participants strategically leverage partnerships and acquisitions to bolster their product portfolios and establish a sustainable competitive edge.

• April 2024 - Merck, known as MSD, outside of the United States and Canada, and North Carolina Agricultural and Technical State University announced the Merck Biotechnology Learning Center opening at Gateway Research Park in Greensboro, North Carolina. The center is a 4,025-square-foot facility with classroom space, a process laboratory, and advanced biopharmaceutical manufacturing equipment.

• April 2024 - Boston Micro Fabrication (BMF) established a business headquartered in San Diego to develop and commercialize 3D BioChips by cultivating large-scale tissues in vitro to help accelerate new drug and cosmetic development. The company has introduced the BMF Biotechnology Inc. business unit to support better the use of highly precise microfluidic solutions in advanced drug development, pharmaceutical, and cosmetic research. BMF Biotechnology Inc. is expected to leverage BMF's Projection Micro Stereolithography (PµSL) 3D printing technology.